Grantham, Mayo, Van Otterloo & Co (GMO)
NUVB icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Nuvation Bio NUVB Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,800
Closed -$21.2K – 650
2023
Q2 		$21.2K Hold
11,800
– – ﹤0.01% 674
2023
Q1 		$19.6K Buy
+11,800
New +$23.9K ﹤0.01% 693

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NUVB Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Nuvation Bio (NUVB) in Q3 2023, closing a stake of 11,800 shares — an estimated $21.2K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NUVB in Q1 2023 and held it in 2 quarters. The position peaked at $21.2K in Q2 2023. 125 funds tracked by Wall St. Rank hold NUVB as of Q3 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Nuvation Bio position as of Q3 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,800 Nuvation Bio shares in Q3 2023, an estimated $21.2K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nuvation Bio in Q1 2023 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Nuvation Bio position peaked at $21.2K in Q2 2023.
  • 125 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.